Access Bio, Inc.
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
950130 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 65 Clyde Road Suite A, Somerset NJ
- Website:
- https://accessbio.net/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Access Bio, Inc. is a biotechnology company dedicated to the prevention and early diagnosis of infectious diseases. It engages in the research, development, manufacturing, and marketing of in vitro rapid diagnostic tests (IVD), biosensors, and molecular diagnostic products. The company is a key partner in global health, recognized for its comprehensive portfolio of tests for diseases such as malaria, HIV, HPV, and COVID-19. Through its products, including the CareStart™ line, Access Bio focuses on providing high-quality, accessible diagnostic solutions to combat serious health threats worldwide, particularly in developing nations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-05 00:00 |
Regulatory News Service
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)
|
Korean | 3.2 KB | ||
| 2025-08-18 00:00 |
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내 )
|
Korean | 3.0 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.8 MB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 3.1 MB | ||
| 2025-08-14 00:00 |
Earnings Release
반기또는분기매출액미달사실발생
|
Korean | 6.0 KB | ||
| 2025-08-14 00:00 |
Delisting Announcement
기타시장안내 (상장적격성 실질심사 관련)
|
Korean | 3.2 KB | ||
| 2025-08-14 00:00 |
Delisting Announcement
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
|
Korean | 4.6 KB | ||
| 2025-05-20 00:00 |
Remuneration Information
[기재정정]주식매수선택권부여에관한신고
|
Korean | 26.3 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.9 MB | ||
| 2025-04-07 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 88.3 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 28.5 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.6 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.7 KB | ||
| 2025-03-18 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 2.8 MB | ||
| 2025-03-11 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 15.7 KB |
Automate Your Workflow. Get a real-time feed of all Access Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Access Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
